Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia
- 31 January 1992
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 92 (1) , 31-40
- https://doi.org/10.1016/0021-9150(92)90007-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart StudyThe American Journal of Cardiology, 1989
- Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart StudyJAMA, 1988
- COMPARISON BETWEEN SIMVASTATIN AND BEZAFIBRATE IN EFFECT ON PLASMA LIPOPROTEINS AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLAEMIAThe Lancet, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- BezafibrateDrugs, 1987
- Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemiaAtherosclerosis, 1985
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978